Efficacy and Tolerability of Intravenous Paricalcitol in Calcitriol-Resistant Hemodialysis Patients with Secondary Hyperparathyroidism: 12-Month Prospective Study

By Tonbul Halil Zeki   Solak Yalcin   Atalay Huseyin   Turkmen Kultigin   Altintepe Lutfullah  

Renal Failure, Vol. 34, Iss. 3, 2012-04 ,pp. : 297-303

Informa Healthcare

Access to resources Recommend Favorite

Local Calcitriol Injections as a Suppressive Treatment of Secondary Hyperparathyroidism in Chronic Dialysis Patients

By Junik Roman   Polanska Magdalena   Manitius Jacek   Doroszewski Witold   Sypniewska Grazyna   Gruszka Marzenna  

Renal Failure, Vol. 29, Iss. 8, 2007-11 ,pp. : 941-945

Informa Healthcare

Access to resources Recommend Favorite

Intravenous Alfacalcidol Once Weekly Pulse Therapy for Secondary Hyperparathyroidism in Hemodialysis Patients

By El-Shafey Eid Mohamed   Alsahow Ali Eid   El-Nagar Gamal Fathy   Ezzat Amal  

Renal Failure, Vol. 33, Iss. 3, 2011-04 ,pp. : 329-333

Informa Healthcare

Access to resources Recommend Favorite

Remarkable increase in lumbar spine bone mineral density and amelioration in biochemical markers of bone turnover after parathyroidectomy in elderly patients with primary hyperparathyroidism: a 5-year follow-up study

By Tamura Yoshiaki   Araki Atsushi   Chiba Yuko   Mori Seijiro   Hosoi Takayuki   Horiuchi Toshiyuki  

Journal of Bone and Mineral Metabolism, Vol. 25, Iss. 4, 2007-07 ,pp. : 226-231

Springer Publishing Company

Access to resources Recommend Favorite

Incidence and risk factors of coronary heart disease in elderly patients on chronic hemodialysis

By Soubassi Lygeri   Chiras Theodore   Papadakis Emmanuel   Poulos George   Chaniotis Dimitrios   Tsapakidis Ioannis   Soubassi Sofia   Zerefos Stylianos   Zerefos Nikolaos   Valis Dimitrios  

International Urology and Nephrology, Vol. 38, Iss. 3-4, 2006-12 ,pp. : 795-800

Springer Publishing Company

Access to resources Recommend Favorite